In this episode, hosts Brad and Michael are joined by plastic surgeons leading the way in medical weight loss: Dr. Alan Durkin, Dr. Johnny Franco, and Dr. Jonathan Kaplan. They discuss the evolving regulatory landscape surrounding weight loss drugs like tirzepatide and semaglutide, the impact of the FDA removing certain drugs from the shortlist, and key compliance considerations for practices offering these treatments. Tune in for insights on navigating the complexities of medical weight loss from those shaping the industry.
Subscribe to our YouTube channel: https://www.youtube.com/@byrdadatto
Stay connected for the latest business and health care legal updates:
Website
Facebook
Instagram
LinkedIn
